Get started
Author

Yosef Joseph Rene Amel Riazat‐Kesh

Observed names: Riazat-Kesh, Yosef J R A, Riazat-Kesh, Yosef JRA, Yosef J. R. A. Riazat-Kesh, Yosef J. Riazat-Kesh, Yosef J.R.A Riazat-Kesh, Yosef J.R.A. Riazat-Kesh, Yosef Joseph Rene Amel Riazat Kesh, Yosef Joseph Rene Amel Riazat-Kesh, Yosef Joseph Rene Amel Riazat-kesh, Yosef Riazat-Kesh
Observed institutions: Mount Sinai Hospital, Mount Sinai Hospital, NewYork–Presbyterian Hospital, Tisch Cancer Institute, Weill Cornell Medical Center, Icahn School of Medicine at Mount Sinai
ORCID: 0000-0003-4912-607X
Observed ORCID: 0000-0003-4912-607X
OpenAlex ID: A5080810933
Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy
2023 · Sam O. Kleeman, Tuba Mansoor Thakir, et al. · Cell Genomics · 37
PDF
An overlooked mimic? Autoimmune myelofibrosis—A scoping review of the literature
2023 · Yosef Joseph Rene Amel Riazat‐Kesh, Alexander Maraveyas, et al. · European Journal Of Haematology · 9
PDF
Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement
2023 · Dahniel Sastow, Joshua Tatarian, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
‘Secondary’ acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?
2023 · Yosef Joseph Rene Amel Riazat-Kesh, John Mascarenhas, et al. · Blood Reviews · 7
Cystatin C is glucocorticoid-responsive, directs recruitment of Trem2+ macrophages and predicts failure of cancer immunotherapy
2021 · Sam O. Kleeman, Breanna Demestichas, et al. · medRxiv · 6
PDF
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
2023 · Douglas Tremblay, Zaker I. Schwabkey, et al. · Blood · 2
TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms
2024 · Shivani Handa, Yosef Joseph Rene Amel Riazat-Kesh, et al. · Blood · 1
PDF
Array CGH + SNP in ALL Enhances Detection of Complex Cytogenetic Profiles and Suggests That PRSS1 Loss May Play a Role in Leukemogenesis
2023 · Hannah Levavi, Daiva Ahire, et al. · Blood · 1
ALL-625 Methotrexate Neurotoxicity in Adult Acute Lymphoblastic Leukemia
2023 · Hannah Levavi, Andre Khazak, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
PDF
Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement
2022 · Dahniel Sastow, Yosef J.R.A Riazat-Kesh, et al. · Blood · 1
Cancer Chemoimmunotherapy: Time Will Tell
2026 · Sam O. Kleeman, Yosef Riazat-Kesh, et al. · Cancer Immunology Research
Induction failure (IF) as a prognostic marker in adult acute lymphoblastic leukemia (ALL).
2026 · Yosef Joseph Rene Amel Riazat Kesh, Sarra Yekta, et al. · Journal of Clinical Oncology
Socioeconomic Disparities in Allogeneic Transplant Access Within a Publicly Funded Healthcare System
2025 · Stephen P. Hibbs, Yosef Joseph Rene Amel Riazat‐Kesh, et al. · eJHaem
PDF
AML-178 A Multi-institutional Analysis of Outcomes in Acute Myeloid Leukemia Patients With Central Nervous System Involvement
2023 · Dahniel Sastow, Joshua Tatarian, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-178 A Multi-Institutional Analysis of Outcomes in Acute Myeloid Leukemia Patients With Central Nervous System Involvement
2023 · Dahniel Sastow, Joshua Tatarian, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ALL-625 Methotrexate Neurotoxicity in Adult Acute Lymphoblastic Leukemia
2023 · Hannah Levavi, Andre Khazak, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy
2023 · Kleeman, Sam O; https://orcid.org/0000-0003-1720-8804, Thakir, Tuba Mansoor, et al. · Zurich Open Repository and Archive (University of Zurich)
Pb2231: an Overlooked Mimic? Autoimmune Myelofibrosis - a Scoping Review of the Literature
2023 · Yosef Joseph Rene Amel Riazat-Kesh, Alexander Maraveyas, et al. · HemaSphere
Enhancing patient clinical streamlining (EPACS) pilot in the breast medicine service at memorial sloan kettering cancer center.
2023 · Yosef Joseph Rene Amel Riazat-Kesh, Madeline Rose Miceli, et al. · Journal of Clinical Oncology
Abstract 2891: Cystatin C is glucocorticoid-responsive, directs recruitment of Trem2+ macrophages and predicts failure of cancer immunotherapy
2023 · Sam O. Kleeman, Breanna Demestichas, et al. · Cancer Research
Abstract 5517: Pegaspargase is a viable option in elderly adults with acute lymphoblastic leukemia
2023 · Yosef Joseph Rene Amel Riazat-Kesh, Hannah Levavi, et al. · Cancer Research
Cystatin C is glucocorticoid-responsive, directs recruitment of Trem2+ macrophages and predicts failure of cancer immunotherapy
2022 · Kleeman, Sam O, Demestichas, Breanna, et al. · Zurich Open Repository and Archive (University of Zurich)
Works count: 24
Citation count: 72
H-index: 5
I10-index: 1
Year
Topic
Type